Emerald Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $796K | Buy |
1,021
+386
| +61% | +$301K | 0.1% | 55 |
|
|
2025
Q1 | $524K | Hold |
635
| – | – | 0.07% | 63 |
|
|
2024
Q4 | $490K | Hold |
635
| – | – | 0.07% | 62 |
|
|
2024
Q3 | $583K | Hold |
635
| – | – | 0.08% | 58 |
|
|
2024
Q2 | $575K | Hold |
635
| – | – | 0.09% | 56 |
|
|
2024
Q1 | $494K | Hold |
635
| – | – | 0.09% | 59 |
|
|
2023
Q4 | $370K | Hold |
635
| – | – | 0.07% | 65 |
|
|
2023
Q3 | $341K | Buy |
635
+1
| +0.2% | +$537 | 0.08% | 64 |
|
|
2023
Q2 | $297K | Buy |
634
+1
| +0.2% | +$469 | 0.07% | 69 |
|
|
2023
Q1 | $217K | Sell |
633
-6
| -0.9% | -$2.06K | 0.06% | 76 |
|
|
2022
Q4 | $234K | Buy |
639
+17
| +3% | +$6.22K | 0.06% | 66 |
|
|
2022
Q3 | $201K | Buy |
622
+1
| +0.2% | +$323 | 0.06% | 74 |
|
|
2022
Q2 | $201K | Buy |
+621
| New | +$201K | 0.06% | 81 |
|